Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice

Haematologica

Volumn 97, Issue 12, 2012, Pages 1836-1844

  Hudson, Krystalyn E ^a   Hendrickson, Jeanne E ^a   Cadwell, Chantel M ^a   Iwakoshi, Neal N ^b   Zimring, James C ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c PUGET SOUND BLOOD CENTER   (United States)

Author keywords

B cells; Erythrocyte specific; Self antigen; T cells; Tolerance

Indexed keywords

ERYTHROCYTE ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ERYTHROID CELL; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; AUTOANTIGENS; B-LYMPHOCYTES; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MURAMIDASE; T-LYMPHOCYTES;

EID: 84870396198     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.065144     Document Type: Article

References (50)

1. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hemato. 2002;69 (4):258-71.
2. Lechner K, Jager U. How I treat autoimmune hemolytic anemias in adults. Blood.2010;116(11):1831-8.
3. Vos GH, Petz LD, Hugh Fudenberg H. Specificity and Immunoglobulin Characteristics of Autoantibodies in Acquired Hemolytic Anemia. J Immunol. 1971;106(5):1172-6.
4. Meite M, Léonard S, Idrissi ME, Izui S, Masson PL, Coutelier JP. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J Virol. 2000;74(13): 6045-9.
5. Efremov D, Ivanovski M, Burrone O. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia. Leuk Lymphoma. 1998;28:285-93.
6. Coutelier JP, Detalle L, Musaji A, Meite M, Izui S. Two-Step Mechanism of Virus-induced Autoimmune Hemolytic Anemia. Ann NY Acad Sci. 2007;1109:151-7.
7. Petz LD, Garratty G. Immune Hemolytic Anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004.
8. Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Oxford: Blackwell Publishing, 2005
9. Branch D, Petz L. Detecting alloantibodies in patients with autoantibodies. Transfusion. 1999;39(1):6-10.
10. Ding C, Yan J. Regulation of autoreactive B cells: checkpoints and activation Archivum Immunologiae et. Therapiae Experimentalis. 2006;55(2):83-9.
11. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol. 2006;6(10):728-40.
12. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19(1):595-621.
13. Palis J, Segel GB. Developmental biology of erythropoiesis. Blood Rev. 1998;12(2):106-14.
14. Bony V, Gane P, Bailly P, Cartron JP. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol. 1999; 107(2):263-74.
15. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci USA. 2009;106(41):17413-8.
16. Barker RN, Casswell KM, Elson CJ. Identification of murine erythrocyte autoantigens and cross-reactive rat antigens. Immunology. 1993;78(4):568-573.
17. Naysmith JD, Ortega-Pierres MG, Elson CJ. Rat erythrocyte-induced anti-erythrocyte autoantibody production and control in normal mice. Immunol Rev. 1981;55:55-87.
18. Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata T, Kumagai S, et al. A transgenic model of autoimmune hemolytic anemia. J Exp Med. 1992;175(1):71-9.
19. Murakami M, Honjo T. Anti-red blood cell autoantibody transgenic mice: murine model of autoimmune hemolytic anemia. Sem Immunol. 1996;8(1):3-9.
20. Murakami M, Nakajima K, Yamazaki K, Muraguchi T, Serikawa T, Honjo T. Effects of Breeding Environments on Generation and Activation of Autoreactive B-1 Cells in Anti-red Blood Cell Autoantibody Transgenic Mice. J Exp Med. 1997;185(4): 791-4.
21. Murakami M, Tsubata T, Shinkura R, Nisitani S, Okamoto M, Yoshioka H, et al. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med. 1994;180(1):111-121.
22. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood. 2009;114(11):2315-22.
23. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988;334(6184):676-82.
24. Zimring JC, Cadwell CM, Chadwick TE, Spitalnik SL, Schirmer D, Wu T, et al. Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood. 2007;110(6):2201-8.
25. Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood. 2010;115(19):3989-96.
26. Zimring JC, Hair GA, Chadwick TE, Deshpande SS, Anderson KM, Hillyer CD, et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood. 2005;106(3):1105-12.
27. Cadwell CM, Zimring JC. Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: a potential role for rheumatoid factor. Vox Sang. 2008;95(2):159-62.
28. Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H. Virus-specific major MHC class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur J Immunol. 1998;28(1):390-400.
29. Honjo K, Xu X, Bucy RP. CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition. Transplantation. 2004;77(3):452-5.
30. Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, et al. B Cell Receptor-independent Stimuli Trigger Immunoglobulin (Ig) Class Switch Recombination and Production of IgG Autoantibodies by Anergic Self-Reactive B Cells. J Exp Med. 2003;197(7):845-60.
31. von Boehmer H, Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol. 2010;11(1):14-20.
32. + T Cell Frequency Varies for Different Epitopes and Predicts Repertoire Diversity and Response Magnitude. Immunity. 2007;27(2):203-13.
33. Hoffman PC. Immune hemolytic anemia- selected topics. ASH Education Program Book. 2009;2009(1):80-6.
34. Hoyer KK, Kuswanto WF, Gallo E, Abbas AK. Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood. 2009;113(2):389-395.
35. Clausen H, Hakomori S-I. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang. 1989;56(1):1-20.
36. Russo D, Wu X, Redman CM, Lee S. Expression of Kell blood group protein in nonerythroid tissues. Blood. 2000;96(1): 340-6.
37. Barker RN, Casswell KM, Reid ME, Sokol RJ, Elson CJ. Identification of autoantigens in autoimmune haemolytic anaemia by a non-radioisotope immunoprecipitation method. Br J Haematol. 1992;82(1):126-32.
38. Leddy JP, Falany JL, Kissel GE, Passador ST, Rosenfeld SI. Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies. J Clin Invest. 1993;91(4):1672-80.
39. Vos GH, Petz LD, Fudenberg HH. Specificity and immunoglobulin characteristics of autoantibodies in acquired hemolytic anemia. J Immunol. 1971;106 (5):1172-6.
40. Rojewski MT, Schrezenmeier H, Flegel WA. Tissue distribution of blood group membrane proteins beyond red cells: Evidence from cDNA libraries. Transf Apher Sci. 2006;35(1):71-82.
41. Reid M, Lomas-Francis C. The Blood Group Antigen Facts Book. 2nd ed. Amsterdam: Elsevier Academic Press, 2004.
42. Ota T, Ota M, Duong BH, Gavin AL, Nemazee D. Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing. J Exp Med. 2011;208(3):617-29.
43. Watkins WM. The ABO blood group system: historical background. Transfus Med. 2001;11(4):243-65.
44. Kantor AB, Stall AM, Adams S, Herzenberg LA. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci USA. 1992;89(8):3320-4.
45. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol. 2002;20(1):253-300.
46. Goodnow CC. Transgenic Mice and Analysis of B-Cell Tolerance. Ann Rev Immunol. 1992;10(1):489-518.
47. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 1989;337(6207):562-6.
48. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant Autoantibody Production by Early Human B Cell Precursors. Science. 2003;301(5638):1374-7.
49. Chu HH, Moon JJ, Kruse AC, Pepper M, Jenkins MK. Negative Selection and Peptide Chemistry Determine the Size of Naive Foreign Peptide-MHC Class II-Specific CD4+ T Cell Populations. J Immunol. 2010;185(8):4705-13.
50. Rieben R, Tucci A, Nydegger UE, Zubler RH. Self tolerance to human A and B histoblood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro. Eur J Immunol. 1992;22(10):2713-7.